Table 3.
Bivariate correlations between serum PON1 activity and fatty acid composition of HDL particles between groups.
| Fatty acids (percent of total FA) | Serum PON1 activity | ||
|---|---|---|---|
| Group 1 (HDL ≤ 39) | Group 2 (39 < HDL ≤ 49) | Group 3 (49 < HDL) | |
| SFA | 0.021 | −0.147 | 0.038 |
| C14:0 (myristic acid) | 0.155 | −0.296* | −0.074 |
| C16:0 (palmitic acid) | −0.044 | −0.192 | 0.078 |
| C18:0 (stearic acid) | −0.060 | 0.133 | 0.078 |
| C20:0 (arachidic acid) | 0.006 | −0.315* | −0.106 |
| UFA | −0.021 | 0.147 | −0.038 |
| MUFA | 0.487** | −0.184 | −0.126 |
| C14:1 (myristoleic acid) | 0.106 | −0.342* | −0.168 |
| C16:1 (palmitoleic acid) | 0.457** | −0.058 | −0.203 |
| C18:1 (oleic acid) | 0.474** | −0.189 | −0.099 |
| PUFA | −0.211 | 0.251 | 0.033 |
| C18:3n3 (ALA) | −0.235 | −0.301* | 0.112 |
| C20:3n3 (ETE) | −0.141 | −0.297* | 0.130 |
| C20:5n3 (EPA) | 0.352* | −0.295* | −0.106 |
| C22:6n3 (DHA) | −0.260 | 0.191 | −0.077 |
| C18:2n6c (LA) | −0.332* | −0.145 | 0.201 |
| C20:3n6 (DGLA) | 0.402** | 0.144 | 0.136 |
| C20:4n6 (AA) | 0.222 | 0.425** | −0.250 |
|
| |||
| SFA : UFA ratio | −0.006 | −0.144 | 0.040 |
| SFA : MUFA ratio | −0.414** | 0.082 | 0.165 |
| SFA : PUFA ratio | 0.091 | −0.215 | 0.008 |
| Total ω3 fatty acids | −0.231 | 0.002 | −0.086 |
| Total ω6 fatty acids | −0.037 | 0.177 | 0.074 |
| ω6 : ω3 ratio | 0.190 | −0.054 | 0.127 |
| AA : EPA ratio | −0.227 | 0.205 | 0.047 |
| EPA : DHA ratio | 0.339 | −0.310* | −0.007 |
ALA: α-linolenic acid, ETE: eicosatrienoic acid, EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid, LA: linoleic acid, DGLA: dihomo-gamma-linolenic acid, AA: arachidonic acid, SFA: saturated fatty acids, UFA: unsaturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids.
(*Significant at the level of 0.05).
(**Significant at the level of 0.01).